UNLABELLED: The objective of this study is to evaluate whether patient-reported baseline health-related quality of life (HRQL) measured by the Functional Assessment of Cancer Therapy-General (FACT-G) instrument is predictive of survival for patients with advanced lung cancer. METHODS: Consecutive patients with advanced lung cancer planning to undergo palliative chemotherapy in the outpatient clinics of a Canadian tertiary care cancer centre were enrolled on study. FACT-G total scores and clinical predictors of survival (age, sex, histology, stage of disease, previous weight loss, presence of liver metastases and performance status) were prospectively collected at baseline. Survival data was subsequently collected retrospectively from the Alberta Cancer Registry. Stratified Cox Proportional Hazards analysis was done examining the influence of baseline total FACT-G scores on survival, controlling for potential clinical confounders. RESULTS: Median survival of the 42 patient cohort was 9.9 months with a 2-year survival of 16.7%. Multivariate analysis indicated that baseline FACT-G total score is significantly associated with survival (p = 0.004). CONCLUSION: Baseline HRQL is a statistically significant predictor of survival for patients with advanced lung cancer. When used along with traditional clinical factors, patient-reported baseline HRQL assessment using the FACT-G provides additional prognostic information to the patient and clinician.
UNLABELLED: The objective of this study is to evaluate whether patient-reported baseline health-related quality of life (HRQL) measured by the Functional Assessment of Cancer Therapy-General (FACT-G) instrument is predictive of survival for patients with advanced lung cancer. METHODS: Consecutive patients with advanced lung cancer planning to undergo palliative chemotherapy in the outpatient clinics of a Canadian tertiary care cancer centre were enrolled on study. FACT-G total scores and clinical predictors of survival (age, sex, histology, stage of disease, previous weight loss, presence of liver metastases and performance status) were prospectively collected at baseline. Survival data was subsequently collected retrospectively from the Alberta Cancer Registry. Stratified Cox Proportional Hazards analysis was done examining the influence of baseline total FACT-G scores on survival, controlling for potential clinical confounders. RESULTS: Median survival of the 42 patient cohort was 9.9 months with a 2-year survival of 16.7%. Multivariate analysis indicated that baseline FACT-G total score is significantly associated with survival (p = 0.004). CONCLUSION: Baseline HRQL is a statistically significant predictor of survival for patients with advanced lung cancer. When used along with traditional clinical factors, patient-reported baseline HRQL assessment using the FACT-G provides additional prognostic information to the patient and clinician.
Authors: A Coates; D Thomson; G R McLeod; P Hersey; P G Gill; I N Olver; R Kefford; R M Lowenthal; G Beadle; E Walpole Journal: Eur J Cancer Date: 1993 Impact factor: 9.162
Authors: H Bülzebruck; R Bopp; P Drings; E Bauer; S Krysa; G Probst; G van Kaick; K M Müller; I Vogt-Moykopf Journal: Cancer Date: 1992-09-01 Impact factor: 6.860
Authors: David Cella; Joseph C Cappelleri; Andrew Bushmakin; Claudie Charbonneau; Jim Z Li; Sindy T Kim; Isan Chen; M Dror Michaelson; Robert J Motzer Journal: J Oncol Pract Date: 2009-03 Impact factor: 3.840
Authors: B K Hamilton; A D Law; L Rybicki; D Abounader; J Dabney; R Dean; H K Duong; A T Gerds; R Hanna; B T Hill; D Jagadeesh; M E Kalaycio; C Lawrence; L McLellan; B Pohlman; R M Sobecks; B J Bolwell; N S Majhail Journal: Bone Marrow Transplant Date: 2015-06-01 Impact factor: 5.483
Authors: Sacha Bhinder; Noori Chowdhury; John Granton; Murray Krahn; D Elizabeth Tullis; Thomas K Waddell; Lianne G Singer Journal: J Med Internet Res Date: 2010-08-19 Impact factor: 5.428
Authors: Franck Bonnetain; Xavier Paoletti; Sandra Collette; Michel Doffoel; Olivia Bouché; Jean Luc Raoul; Philippe Rougier; Fadil Masskouri; Jean Claude Barbare; Laurent Bedenne Journal: Qual Life Res Date: 2008-07-10 Impact factor: 4.147
Authors: Jennifer L Steel; David A Geller; Tiana L Robinson; Alexandra Y Savkova; Deborah S Brower; J Wallis Marsh; Allan Tsung Journal: Cancer Date: 2014-08-07 Impact factor: 6.860